The scorecard investors already run on your commercialization plan
Most founders assume a pitch lives or dies on the technology. The panelists on this year’s Designing for Commercialization session at Houston MedTech Oktoberfest made a different case: by the time a team is in the room, investors have usually already decided the science is credible. What they’re actually evaluating is everything sitting quietly around…